Dividend Changes to Know Now: Merck, McCormick, Triangle Capital, Tyco Electronics, RG Barry

Merck & Co. Inc. (NYSE:MRK): Merck increases dividend 1c to 43c per share. Merck announced that its board has increased the company’s quarterly dividend to 43c per outstanding share of the company’s common stock, up 1c from 42c per outstanding share paid last quarter. Payment will be made on Jan. 8, 2013, to shareholders of record at the close of business on Dec. 17.

McCormick & Co. Inc. (NYSE:MKC): McCormick increases quarterly dividend to 34c from 31c. The board of McCormick & Company declared an increase in the quarterly dividend from 31c to 34c per share on its common stocks, payable January 14, 2013 to shareholders of record December 31.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Triangle Capital Corporation (NASDAQ:TCAP): Triangle Capital increases quarterly dividend by 12.8% to 53c. The dividend is payable on December 26 to stockholders of record on December 12.

Tyco Electronics, Ltd. (NYSE:TEL): TE Connectivity board to propose 19% increase of annualized dividend to $1.00. TE Connectivity’s board of directors approved a recommendation to increase the company’s quarterly dividend 19%, from 21c to 25c per share for the four fiscal quarters beginning with Q3 2013. The recommendation would raise the company’s dividend from the annual rate of 84c per share to $1.00 per share. This recommendation will be presented for shareholder approval at the company’s annual general meeting of shareholders in March 2013.

RG Barry Corp. (NASDAQ:DFZ): RG Barry Corp increases quarterly dividend by 12.5%. The board increases the quarterly dividend to 9c per share from 8c per share. The board declared an accelerated dividend of 9c per share payable on December 28 to shareholders of record on December 14. The payment of the dividend is intended by the board to be in lieu of the quarterly dividend that would have been paid in March 13. The next quarterly dividend, if declared by the board, is expected to be paid in June 2013.

Don’t Miss: Will This Purchase Boost Sales for GlaxoSmithKline?

More Articles About:   , , , ,